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Genetic and Pharmacological Analysis Identifies
a Physiological Role for the AHR in Epidermal
Differentiation
Ellen H. van den Bogaard1, Michael A. Podolsky2, Jos P. Smits1, Xiao Cui2, Christian John2, Krishne Gowda3,
Dhimant Desai3, Shantu G. Amin3, Joost Schalkwijk1, Gary H. Perdew2 and Adam B. Glick2
Stimulation of the aryl hydrocarbon receptor (AHR) by xenobiotics is known to affect epidermal differentiation
and skin barrier formation. The physiological role of endogenous AHR signaling in keratinocyte differentiation is
not known. We used murine and human skin models to address the hypothesis that AHR activation is required
for normal keratinocyte differentiation. Using transcriptome analysis of Ahr / and Ahrþ /þ murine keratino-
cytes, we found significant enrichment of differentially expressed genes linked to epidermal differentiation.
Primary Ahr / keratinocytes showed a significant reduction in terminal differentiation gene and protein
expression, similar to Ahrþ /þ keratinocytes treated with AHR antagonists GNF351 and CH223191, or the selective
AHR modulator (SAhRM) SGA360. In vitro keratinocyte differentiation led to increased AHR levels and
subsequent nuclear translocation, followed by induced CYP1A1 gene expression. Monolayer cultured primary
human keratinocytes treated with AHR antagonists also showed an impaired terminal differentiation program.
Inactivation of AHR activity during human skin equivalent development severely impaired epidermal stratifica-
tion, terminal differentiation protein expression, and stratum corneum formation. As disturbed epidermal
differentiation is a main feature of many skin diseases, pharmacological agents targeting AHR signaling or future
identification of endogenous keratinocyte-derived AHR ligands should be considered as potential new drugs in
dermatology.
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INTRODUCTION
The aryl hydrocarbon receptor (AHR) is a ligand-activated
transcription factor and member of the bHLH/PAS (basic
Helix-Loop-Helix/Per-Arnt-Sim) family (Shimizu et al., 2000;
Omiecinski et al., 2010). The AHR regulates metabolism
of drugs and environmental toxicants. Compounds such as
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and polycyclic
aromatic hydrocarbons, as well as plant polyphenols and
tryptophan photoproducts, are primarily agonists, although
some flavonoid antagonists have been described (Murray
et al., 2010a). The AHR resides in a cytoplasmic
multiprotein complex, which translocates to the nucleus
upon agonist binding. There the receptor dissociates from
HSP90 and dimerizes with the aryl hydrocarbon nuclear
translocator (ARNT) to transactivate target genes primarily
through dioxin response elements (DRE) in promoters of
responsive genes (Omiecinski et al., 2010). In humans,
TCDD toxicity causes chloracne, which is associated with
epidermal hyperproliferation and hyperkeratinization (Poland
and Knutson, 1982), and increased expression of genes critical
for the formation of the cornified envelope (Greenlee et al.,
1985; Loertscher et al., 2001; Sutter et al., 2009; Sutter et al.,
2011). In cell culture, TCDD induces the expression of genes
in the epidermal differentiation complex, causing aberrant
differentiation of keratinocytes (Geusau et al., 2005;
Sutter et al., 2009; Sutter et al., 2011). Six- to eight-month-
old Ahr / mice exhibit alopecia associated with dystrophic
and degenerating hair follicles, ulceration, and regenerative
hyperplasia (Fernandez-Salguero et al., 1997). We recently
demonstrated in atopic dermatitis that coal tar therapy
activates the AHR through an unknown agonist(s) and
restores defective differentiation and barrier function (Van
den Bogaard et al., 2013). Together, these data suggest that
dysregulation of normal AHR function could be important in
the pathogenesis of chronic skin diseases with aberrant
epidermal differentiation.
In addition to pathological AHR agonists such as TCDD,
other AHR ligands can act either as full antagonists or
selective modulators of AHR function with overlapping but
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nonidentical effects on AHR cellular activities in the cell
(Boitano et al., 2010; Murray et al., 2010b; Smith et al., 2011;
Choi et al., 2012; Lahoti et al., 2013). These too may have
significant therapeutic potential in suppressing some or all of
the AHR-driven pathways in human disease. However, despite
this extensive characterization of the pathogenesis and
molecular biology of cutaneous responses to TCDD (Chiaro
et al., 2008a; Veldhoen et al., 2009; Schroeder et al., 2010),
the role of the AHR in normal epidermal differentiation and
homeostasis and the potential role of AHR ligands in therapy
for cutaneous disease is poorly understood. Here we show that
in vitro expression of differentiation genes and proteins is
suppressed in Ahr / keratinocytes, that the AHR undergoes
nuclear translocation during in vitro differentiation, and that
AHR antagonists and selective modulators can block
differentiation of human and mouse keratinocytes in mono-
layer culture and in human skin equivalents. These data
underscore a significant physiological role of the AHR in
normal epidermal differentiation.
RESULTS
The AHR regulates epidermal differentiation, attachment, and
inflammatory cytokine gene expression
To identify AHR-dependent genes, we compared gene expres-
sion between Ahrþ /þ and Ahr / keratinocytes cultured in
0.05 mM Ca2þ growth medium using Affymetrix ST arrays
and ArrayStar 11 Software (DNASTAR, Madison, WI). We
identified 391 genes whose expression was altered by at
least 1.5-fold (Po0.05) in Ahr / keratinocytes relative to
Ahrþ /þ . We used the DAVID Bioinformatics Software (Huang
et al., 2009b) to identify functional annotation clusters within
the group of differentially regulated genes, and consistent with
initial analysis the top functional annotation clusters were
extracellular matrix and adhesion (Enrichment score 7.2, 5.4;
P¼7.3 107 and 9.7 10 8, respectively) and keratino-
cyte, epidermal cell differentiation (Enrichment score 3.3;
P¼2.1 107). Of the top downregulated transcripts in
Ahr / keratinocytes, 22 were linked to epidermal differen-
tiation, including those for structural proteins, proteins involved
in the formation of the cornified envelope, proteases and
protease inhibitors, and the transcription factor Pou2f3 (Skin1;
Supplementary Table S1 online). Thirteen of the top upregu-
lated transcripts in Ahr / keratinocytes encoded proteins
associated with extracellular matrix and adhesion (Supple-
mentary Table S2 online). Expression of genes linked to skin
inflammatory diseases, Il33, Il36g, and thymic stromal lym-
phopoietin (Tslp), was downregulated in Ahr / keratino-
cytes, whereas the expression of Il24 and Il18r was induced
(Supplementary Table S1 and S2 online).
We compared the expression of representative epidermal
differentiation genes in Ahrþ /þ and Ahr / keratinocytes
cultured in proliferation medium or 24 hours after switching to
differentiation medium (0.12 mM Ca2þ ). In the absence of the
AHR, both basal and induced expression levels of Krt1, Lor,
Ivl, Dsc1, and the transcription factor Pou2f3 were signifi-
cantly reduced (Figure 1). Induction of differentiation with
elevated calcium also increased the expression of the well-
characterized AHR target gene Cyp1a1 in Ahrþ /þ keratino-
cytes, but it was blocked in Ahr / keratinocytes (Figure 1).
As expected, TCDD caused a significant induction of Cyp1a1
in Ahrþ /þ , but not in Ahr / , keratinocytes (data not shown).
Similarly, both Il33 and Il36g were significantly repressed in
Ahr / keratinocytes relative to Ahrþ /þ in cells cultured in
proliferation medium (Supplementary Figure S1 online).
AHR antagonists and selective modulators block epidermal
differentiation in monolayer culture
AHR ligands that act as either full antagonists or selective
modulators have been identified. GNF351 is a full antagonist
of DRE and non-DRE AHR function, it interacts directly with
the AHR ligand binding pocket, and it competes with a well-
characterized photoaffinity AHR ligand for binding to the
AHR, with an IC50 of 62 nM (Smith et al., 2011). GNF351
blocks AHR target gene induction by TCDD, but it has no
agonist activity for either DRE-dependent or -independent
functions of the AHR. SGA360 is a selective AHR modulator
(SAhRM), as it blocks TCDD-induced DRE-mediated AHR
activity, but it has agonist-like activity for non-DRE mediated
AHR functions (Patel et al., 2009b; Tanos et al., 2012).
We treated Ahrþ /þ and Ahr / keratinocytes with TCDD
or Ahrþ /þ differentiating keratinocytes with GNF351 or
SGA360, and we measured changes in gene expression by
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Figure 1. Downregulation of differentiation gene expression in Ahr / mouse keratinocytes. Expression of indicated genes during calcium-induced
differentiation of primary Ahrþ /þ and Ahr / keratinocytes was determined by quantitative PCR from triplicate cultures, and it was repeated twice. Expression
was normalized to Gapdh. Krt1, Keratin 1; Lor, Loricrin; Ivl, Involucrin; Dsc1, Desmocollin 1; Pou2f3, POU Class 2 Homeobox 3, Cyp1a1; Cytochrome P450 1A1.
*significantly different from Ahr þ /þ Po0.05.
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quantitative real-time reverse-transcriptase–PCR. Consistent
with its known effects, TCDD induced the expression of
genes involved in epidermal differentiation under prolifera-
tion conditions (Sutter et al., 2011), which was blocked in
Ahr / keratinocytes (Figure 2a). Both GNF351 and
SGA360 suppressed the expression of early (Krt1, Pou2f3)
and late (Ivl, Lor, Dsc1) differentiation genes in both basal and
differentiation culture conditions. Similarly, GNF351 comple-
tely blocked the induction of Cyp1a1 in differentiating
keratinocytes, supporting the concept that the AHR
becomes activated during normal epidermal differentiation
(Figure 2a). In addition, both Il33 and Il36g were significantly
downregulated in Ahrþ /þ keratinocytes treated with
either GNF351 or SGA360 (Supplementary Figure S1 online).
To test whether similar effects occurred in human keratino-
cytes, we treated differentiating human primary keratinocytes
with the AHR antagonists GNF351 and CH223191 and
observed a comparable reduction in expression of
CYP1A1, FLG, hornerin (HRNR), and LOR relative to the
untreated control differentiating keratinocyte cultures. There
was a trend toward induced epidermal differentiation
with the AHR agonist indirubin, but this was not statistically
significant (Figure 2b). FICZ (6-Formylindolo(3,2-b)carbazole),
an AHR agonist generated in the skin from tryptophan
by UV light (Fritsche et al., 2007), also induced the
expression of some, but not all, differentiation genes in
human keratinocytes (Supplementary Figure S2 online).
There was minimal toxicity of these AHR ligands in mouse
or human keratinocytes (Supplementary Figure S3 online).
Immunoblot analysis confirmed that genetic or pharmacolo-
gical inactivation of AHR blocked the induction of keratin 10
and loricrin protein expression in mouse (Figure 2c) and of
involucrin, loricrin, and pro-filaggrin in human keratinocytes
(Figure 2d).
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Figure 2. Aryl hydrocarbon receptor (AHR) antagonists and selective modulators suppress epidermal differentiation in monolayer culture. (a) Effect of 2,3,7,
8-Tetrachloro-p-dibenzodioxin (TCDD; 10 nM), GNF351 (500 nM), and SGA360 (10mM) on gene expression in proliferating (0.05 mM CaCl2) or differentiating
(0.12 mM CaCl2) primary mouse keratinocytes (triplicate, repeated twice). (b) Effect of GNF351 (500 nM), CH223191 (CH, 5mM), and indirubin (IR, 50 nM)
on differentiation gene expression in primary human keratinocytes (two separate experiments, total of n¼ 5 donors). (c) Immunoblot analysis showing the effect of
Ahr ablation, GNF351, or SGA360 on differentiation-induced expression of keratin 10 and loricrin in primary mouse keratinocytes. (d) Immunoblot analysis
showing the effect of GNF351 and CH223191 (CH) on pro-filaggrin (FLG), involucrin (IVL), and loricrin (LOR) in monolayer cultured primary human
keratinocytes. *Po0.05 compared with vehicle control.
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AHR antagonists suppress epidermal differentiation and stratum
corneum thickness in human skin equivalents
To further examine the effect of AHR antagonists on epidermal
differentiation, we generated epidermal skin equivalents using
human primary keratinocytes cultured on plastic inert filters.
We tested the effect of antagonists added at different time
points during generation of the human skin equivalents. When
the keratinocytes were in submerged culture (proliferation/
attachment phase) or when monolayers were initially brought
to the air–liquid interface, the addition of GNF351 or
CH223191 substantially suppressed the stratification process
and the formation of the stratum corneum (Figure 3a). Expres-
sion of late differentiation markers involucrin and filaggrin was
strongly reduced, but the early differentiation marker keratin
10 was less affected (Figure 3b). Addition of antagonists during
the last phase of air–liquid interface culture (from day 4 or 7
onward) resulted in thinning of the stratum corneum, but it did
not affect involucrin or filaggrin expression (Figure 3b). How-
ever, when skin equivalents were generated using de-epider-
mized dermis, treatment with GNF351 4 days after transfer to
the air–liquid interface reduced the expression and number of
cell layers expressing loricrin and filaggrin, whereas the
expression of keratin 10 was delayed (Figure 4). As AHR
antagonists were added during the proliferation phase of the
skin equivalent development (submerged culture), we tested
whether they affected keratinocyte proliferation. There was a
significant reduction in the percentage of Ki67-positive cells
and cell number after treating proliferating monolayer cultures
of human keratinocytes with AHR antagonists for 48 hours
(Figure 5, Supplementary Figure S4 online). In contrast, skin
equivalents generated on inert filters and treated with GNF351
during the submerged phase or at day one of transfer to the
air–liquid interphase had more Ki67-positive basal cells at the
end of the skin equivalent development compared with
untreated cultures (Figure 3b).
Increased AHR nuclear localization during epidermal
differentiation in vitro
To confirm whether the observed AHR dependence of
differentiation gene expression was associated with AHR
nuclear translocation, we isolated nuclear and cytoplasmic
protein from primary mouse keratinocytes at specific time
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Figure 3. Epidermal stratification defects and reduced stratum corneum thickness caused by aryl hydrocarbon receptor (AHR) inactivation. Human skin
equivalents (epidermis only) were generated on plastic inert filters. At indicated time points (arrows) during skin equivalent development (each block represents
one day of culture), AHR antagonists were added to the culture medium. All skin equivalents were harvested at day 10 of air–liquid interface culture.
(a) Hematoxylin and Eosin staining of skin equivalents treated with GNF351 (500 nM) or CH223191 (CH) (5mM). (b) Immunohistochemical staining of Keratin 10
(KRT10, early differentiation), filaggrin (FLG, terminal differentiation), involucrin (IVL, terminal differentiation), and Ki67 (proliferation) of skin equivalents treated
with GNF351, as depicted in Figure 2a (n¼2 keratinocyte donors). Scale bar¼100mm.
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points after induction of differentiation with elevated medium
calcium. Under basal proliferating conditions, AHR protein
expression was detected in the cytosolic extracts, but not in
nuclear extracts (Figure 6a). Six hours after induction of
differentiation, there was an increase in nuclear AHR reaching
a maximum at 12 hours that was sustained through 48 hours.
AHR levels in cytosolic extracts also increased 12 hours after
induction of differentiation, and this was sustained through
48 hours (Figure 6a). ARNT levels retained in the nucleus also
increased during differentiation, whereas slightly reduced
levels were detected in Ahr / keratinocytes (Figure 6a).
Treatment with GNF351 for 24 hours enhanced nuclear AHR
levels under differentiation conditions, whereas SGA360
increased cytosolic AHR levels and prevented nuclear reten-
tion. In proliferating keratinocytes, AHR agonists such as
TCDD and ICZ (indolo[3,2-b]carbazole) caused rapid nuclear
localization followed by significant loss of the protein from
both the nuclear and cytoplasmic compartments, as expected,
most likely owing to proteosomal degradation (Ikuta et al.,
1998; Davarinos and Pollenz, 1999; Ikuta et al., 2000).
GNF351 caused a slower and sustained increase in nuclear
AHR and cytoplasmic AHR, whereas SGA360 completely
blocked the presence of AHR retained in nuclear extracts and
increased cytoplasmic AHR levels.
DISCUSSION
The AHR is the mediator of TCDD toxicity in the skin and
other tissues. TCDD causes induction of keratinocyte terminal
differentiation in vitro, and it accelerates skin barrier function
in utero (Loertscher et al., 2001; Sutter et al., 2011; Muenyi
et al., 2014), suggesting that AHR activation by exogenous
ligands can cause pathological dysregulation of keratinocyte
differentiation. In contrast, recent studies point to the bene-
ficial effects of AHR activation in skin and other tissues and its
potential as a therapeutic target (Qiu et al., 2012; DiMeglio
et al., 2014). However, the role of the AHR in normal skin
physiology is poorly understood. Here we show that normal
epidermal differentiation is regulated by AHR signaling in
both murine and human keratinocytes: Ahr / mouse
keratinocytes have defects in differentiation gene expression;
AHR antagonists and SAhRMs suppress differentiation gene
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Figure 4. Reduced terminal differentiation protein expression caused by aryl hydrocarbon receptor (AHR) inactivation. Human skin equivalents were generated
using de-epidermized dermis, and expression of keratin 10 (KRT10), filaggrin (FLG), and loricrin (LOR) was followed in time by harvesting the skin equivalents
directly after submerged culture, and after 4, 6, and 10 days of air–liquid interface culture (each block represents one day of culture). Treatment with GNF351
(500 nM, arrows) was initiated at day 6 and sustained until day 10 of air–liquid interface culture. Magnification inlays show epidermal differentiation protein
expression affected by AHR inactivation (n¼2 keratinocytes donors). Scale bar¼100mm.
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expression in monolayer culture of human and mouse
keratinocytes and epidermal differentiation and stratification
in human skin equivalent models. These data suggest a phy-
siological role for the AHR during epidermal differentiation
and stratification amenable to manipulation by pharma-
cological AHR antagonists or SAhRMs.
Our results are in concordance with earlier reports of
elevated CYP1A1 enzyme levels in differentiated keratinocytes
in the absence (Sadek and len-Hoffmann, 1994) or presence of
xenobiotics (Reiners et al., 1992), and the response to TCDD
was higher in differentiated keratinocytes (Wanner et al.,
1995; Swanson 2004). In addition, retinoic acid, which
interferes with epidermal differentiation, suppresses AHR
induction during keratinocyte differentiation (Wanner et al.,
1995). In contrast, lentiviral knockdown of the AHR in 3D skin
equivalents had no effect on epidermal morphology (Forrester
et al., 2014), but this may be owing to insufficient AHR
inactivation (40% knockdown) compared with the AHR
antagonists used here. The ability of AHR antagonists to
suppress proliferation in human keratinocyte monolayers is
consistent with cell cycle arrest and reduced proliferation
caused by AHR knockdown in HaCaT cells (Kalmes et al.,
2011). As the AHR can activate the EGFR/extracellular signal–
regulated kinase pathway through c-Src (Fritsche et al., 2007;
Sutter et al., 2009), it is possible that AHR antagonist– and
SAhRM-induced growth inhibition is indirect. However, this is
unlikely, as keratinocyte cultures were supplemented with
EGF. The increased numbers of Ki67-positive cells in skin
equivalents treated with AHR antagonist at early stages of skin
equivalent development is most likely owing to some type of
feedback response to the disturbed differentiation or retention
of cells with a basal cell phenotype owing to suppressed
differentiation.
We observed increased levels of nuclear AHR in mouse
keratinocytes after induction of differentiation. Translocation
and activation of AHR is unlikely to be due to the indirect
mechanism reported by Wincent et al. (2012), whereby
inhibition of CYP1A1 increases culture media levels of the
agonist FICZ, as differentiation induces CYP1A1 enzyme
activity (Reiners et al., 1990; Jones and Reiners, 1997). We
hypothesize rather that keratinocyte differentiation generates
endogenous AHR ligands, which drive translocation and
activation. It is possible that differentiation-induced prosta-
glandin synthesis could mediate the observed nuclear trans-
location of the AHR, as prostaglandins and other arachidonic
acid metabolites can act as AHR agonists (Seidel et al., 2001;
Chiaro et al., 2008b), and increased Cox-2 expression is
associated with epidermal differentiation in vitro and in vivo
(Cameron et al., 1990; Evans et al., 1993; Leong et al., 1996;
Xu et al., 2008), although this remains to be determined
directly. Surprisingly, GNF351 treatment in differentiation and
basal culture conditions also increased the nuclear AHR levels
after 24 hours, whereas SGA360 blocked AHR retention in the
nucleus. This is in direct contrast to AHR agonists TCDD and
ICZ, which cause rapid nuclear translocation, followed by loss
of receptor, as previously reported, suggesting that AHR
nucleocytoplasmic shuttling and degradation induced by
differentiation and AHR antagonists are distinct from that
driven by exogenous agonists (Ikuta et al., 1998; Davarinos
and Pollenz, 1999; Ikuta et al., 2000). Our results also show
distinct mechanisms of action of the pure antagonist GNF351
and the SAhRM SGA360, as GNF351 appears to allow AHR
nuclear translocation but to prevent AHR-mediated gene
expression, whereas SGA360 blocks AHR nuclear translo-
cation. Similar distinctions have been made for the regulation
of inflammatory gene expression by SAhRMs, which is DRE-
independent and involves the inhibition of AHR interaction
with proinflammatory pathways, although pure antagonists
also block nuclear retention of the AHR in other cell types
(Patel et al., 2009a; DiNatale et al., 2010; Smith et al., 2011;
Tanos et al., 2012). Computational analysis has indicated the
presence of DRE in promoters for many terminal differ-
entiation genes, and functional DREs have been identified in
the human FLG gene (Sutter et al., 2011). Our expression
results reveal that keratinocyte differentiation gene expression
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Figure 6. Nuclear localization of aryl hydrocarbon receptor (AHR) during
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receptor nuclear translocator (ARNT) after induction of differentiation with
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primary mouse keratinocytes induced to differentiate in the presence of
GNF351 or SGA360. (c) Immunoblot showing time course of nuclear and
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is suppressed upon ablation or pharmacological inhibition of
AHR activity. In addition, nuclear localization of the AHR
during differentiation suggests that endogenous AHR ligands
drive translocation and binding of AHR/ARNT complexes to
DREs present in the promoter region of differentiation genes,
although this remains to be directly determined through chro-
matin immunoprecipitation and chromatin-immunopreci-
pitation sequencing. Interestingly, ablation of ARNT in
mouse skin or knockdown in human keratinocytes induces
the expression of a number of epidermal differentiation genes
(Geng et al., 2006; Robertson et al., 2012), although Flg and
Lor are reduced in Arnt / skin (Geng et al., 2006), similar
to our findings with Ahr / keratinocytes. However, this
aberrant induction of differentiation gene expression may be
indirect through downregulation of the EGFR ligand amphi-
regulin in the absence of ARNT (Robertson et al., 2012). It is
possible that some effects of AHR ablation or antagonism on
differentiation could be indirect, through downregulation of
the transcription factor Pou2f3 (Skn-1a) critical for epidermal
proliferation and differentiation (Andersen et al., 1997;
Takemoto et al., 2010).
We also observed upregulation of a significant number of
genes encoding extracellular matrix and cell attachment
proteins in Ahr / keratinocytes relative to Ahrþ /þ , but it
is not known whether this represents secondary changes
owing to long-term ablation of AHR function, possible func-
tion of AHR as a repressor of gene expression, or reprogram-
ming of primary keratinocyte epithelial phenotype. In Ahr /
keratinocytes, we found a significant downregulation of three
cytokine genes that are important in different inflammatory
skin diseases Il33, Il36g, and Tslp (Shigeno et al., 2009; Larson
et al., 2010; Carrier et al., 2011; Hueber et al., 2011; Balato
et al., 2012; Tortola et al., 2012). Interestingly, suppression of
Il33 and Il36g expression by GNF351 and SGA360 suggests
that AHR antagonists and selective modulators may be useful
therapeutics for regulating skin inflammation. The observed
upregulation of the proinflammatory cytokine IL24 (Kunz
et al., 2006; Kumari et al., 2013) in Ahr / keratinocytes
indicates that this may be more complex within a treatment
setting.
Similar to our recent finding that AHR activation mediated
by coal tar restores disturbed epidermal differentiation and
improved skin barrier function in atopic dermatitis (Van den
Bogaard et al., 2013), this study opens an additional avenue
for the development of AHR antagonists or selective
modulators that can regulate AHR signaling in keratinocytes
to modulate epidermal differentiation and inflammation.
MATERIALS AND METHODS
Isolation and culture of primary keratinocytes
Primary keratinocytes were isolated from newborn Ahrþ /þ and
Ahr / mice, PCR-genotyped (Schmidt et al., 1996), and cultured
as described in 0.05 mM CaCl2 medium (Markell et al., 2011). Cells
were treated with 10 nM TCDD, 500 nM ICZ, 200 nM GNF351, and
10mM SGA360 or DMSO for the indicated times in either 0.05
or 0.12 mM CaCl2-containing medium. All animal studies were
conducted using protocols approved by the Penn State University
IACUC. Human keratinocytes were isolated from abdominal skin
(Rheinwald and Green, 1975) in accordance with the Declaration of
Helsinki Principles, approval by Radboud University Medical Center,
and written informed patient consent. For submerged culture, kerati-
nocytes were cultured in KGM (Lonza, Slough, UK) and differentiated
by growth factor depletion (Van Ruissen et al., 1996). Cells were
treated with 50 nM indirubin (IR), 500 nM GNF351, 5mM CH223191,
500 nM SR1, and 0.1 and 1mM FICZ at indicated time points or
DMSO as vehicle control.
Microarray analysis
RNA isolated from four independent pooled Ahrþ /þ primary kerati-
nocyte cultures and three Ahr / cultures were reverse transcribed
and hybridized to Affymetrix Mouse Gene ST 2.0 arrays in the Penn
State Genomics Core Facility according to the manufacturers’ proto-
col. Arrays were scanned using a GeneChip Scanner 3000 7G
(Affymetrix, Santa Clara, CA) and analyzed using the ArrayStar 11
Software (DNASTAR, Madison, WI) with RMA background correction
and quantile normalization. Mean log2 signal was used to compare
gene expression between groups and significantly different genes
identified using a 1.5-fold cutoff and P-valueo0.05 using a one-sided
equal variance Student’s t-test. Functional annotation clustering with
genes identified as differentially expressed using ArrayStar 11 was
conducted using the DAVID Bioinformatics Software (Huang et al.,
2009a; Huang et al., 2009b). GEO accession number is GSE62490.
Human skin equivalent development
Human primary keratinocytes were seeded onto plastic inert filters
(ThinCerts, Greiner Bio-one, Breda, The Netherlands) in CnT-PR
medium (CELLnTEC, Bern, Switzerland). After 48 hours, cells were
switched to CnT-PR-3D barrier (CELLnTEC) for 24 hours, and then
cultured at the air–liquid interface for 10 days. Human skin equi-
valents using de-epidermized dermis were generated as described
previously (Van den Bogaard et al., 2012). Skin equivalents were
treated, as indicated, with 500 nM GNF351 or 5mM CH223191.
Immunostaining
Formalin-fixed paraffin-embedded skin equivalents were stained with
hematoxylin and eosin (H&E; Sigma, Sigma-Aldrich, Zwijndrecht,
The Netherlands) or processed for immunohistochemistry. Human
keratinocytes on glass coverslips were treated twice over 48 hours
with AHR antagonists (GNF351, 500 nM; CH223191, 5mM; SR1,
500 nM), fixed with 4% paraformaldehyde, permeabilized with 1%
Triton-X/PBS, and stained for Ki-67. Nuclei were counterstained with
DAPI.
RNA and quantitative real-time reverse-transcriptase–PCR
Total RNA was isolated from keratinocytes using Ribozol, and
quantitative real-time reverse-transcriptase–PCR was performed, as
described, in triplicate (Markell et al., 2011) and normalized to
Gapdh (mouse) or RPLP0 (human). Intron-spanning primer sequences
for analyzed genes were obtained using Primer 3 software (Rozen and
Skaletsky, 2000) with Genebank sequence information.
Western blot analysis
Proteins were isolated from mouse keratinocytes as described (Cheng
et al., 1990; Hogan et al., 2013), and from human keratinocytes with
radioimmunoprecipitation assay buffer. Separated proteins were
detected by ECL (Markell et al., 2011).
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Statistical analysis
For gene expression, statistical significance was determined between
genotypes or between treatment and control using Student’s t-test and
GraphPad Prism4 (GraphPad Software, La Jolla, CA) with significance
determined as a P-value o0.05.
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